Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - KIWA BIO-TECH PRODUCTS GROUP CORP | Financial_Report.xls |
| 10-Q - QUARTERLY REPORT - KIWA BIO-TECH PRODUCTS GROUP CORP | v313967_10q.htm |
| EX-31.2 - EXHIBIT 31.2 - KIWA BIO-TECH PRODUCTS GROUP CORP | v313967_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - KIWA BIO-TECH PRODUCTS GROUP CORP | v313967_ex31-1.htm |
| EX-32.2 - EXHIBIT 32.2 - KIWA BIO-TECH PRODUCTS GROUP CORP | v313967_ex32-2.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Kiwa Bio-Tech Products Group Corporation (the “Company”) on Form 10-Q for the quarter ended March 31, 2012 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Wei Li, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the period presented therein.
Date: May 21, 2012
| By: | /s/ Wei Li |
| Wei Li | |
| Principal Executive Officer |